Stem Cell Research News

A-Z Index

| Hot Topics

> Stem Cell Research

FORMATS: RSS | EMAIL | MOBILE

Latest Stem Cell Research News

New FC Systems Measure More Variables Over Shorter Time Periods 1 Dec 2008 14:31 GMT
... “Manufacturers have responded to the needs of researchers by developing faster systems that can measure ... slow and tedious. With frequencies of one stem cell in a population of millions of circulating ... VenturiOne software in their investigations of cancer-causing stem cells. “Using the old software, we were only ...
Zeroing in on PI3K Pathway 1 Dec 2008 14:31 GMT
... Dec 1 2008 (Vol. 28, No. 21) Myriad of Groups ... one of the hottest targets in cancer research. The latest star is the phosphoinositide 3-kinase ... up will be treatments that eradicate cancer stem cells,” summarized Dr. Garlich. Exelixis is developing two ...
Health-Care Stocks: The Obama Effect 1 Dec 2008 14:14 GMT
... will be a key priority in the Obama Administration. With Democrats ... help the FDA stay current on science-related research and approve new drugs on schedule, and ...
Senate Dems look to GOP moderates for help 1 Dec 2008 14:13 GMT
... nominations, and Sen. , R-Ariz., who has supported some Democratic initiatives, such as embryonic stem cell research funding, that likely will get an early airing during the next session. © 2008 ...
--> Novogen's NV-128, a Novel mTOR Inhibitor, Shows Potential Activity Against Cancer Stem Cells 1 Dec 2008 13:52 GMT
... SYDNEY, AUSTRALIA and NEW CANAAN, CT--(Marketwire - December 1, ... performed in collaboration with a Yale University research team led by Associate Professor Gil Mor, ... has the potential to act against cancer stem cells in addition to rapidly proliferating cells in ...

ImmuneRegen(R) Appoints Wound Healing and Tissue Regeneration Expert Spencer A. Brown, Ph.D. to Advisory Board Company Gains Further Scientific and Biotech Business Expertise to Accelerate Development of, and the Opportunity for C 1 Dec 2008 13:51 GMT
... than 20 years experience as a clinical researcher and biotech company entrepreneur and advisor, is ... that includes preclinical and clinical studies in stem cells, dermatology, reconstructive surgery and wound healing mechanisms, ... ImmuneRegen's drug candidate, Homspera(R), is an adult stem cell active compound that has been shown to ...
Novogen's NV-128, a Novel mTOR Inhibitor, Shows Potential Activity Against Cancer Stem Cells 1 Dec 2008 13:50 GMT
... SYDNEY, AUSTRALIA and NEW CANAAN, CT -- (MARKET WIRE) ... performed in collaboration with a Yale University research team led by Associate Professor Gil Mor, ... has the potential to act against cancer stem cells in addition to rapidly proliferating cells in ...
Macquarie to lay off 69 in Jacksonville 1 Dec 2008 13:04 GMT
... on rehab projects, jobs for nonprofits. The Obama administration may overturn a ban on stem cell research. Are Gen Y’s demands too much for this economy? Get the latest local business ...
Tap the underlying opportunities in rapidly growing field of Stem cell biology 1 Dec 2008 12:31 GMT
... underlying opportunities in rapidly growing field of Stem cell biology Manipal Institute of Regenerative Medicine offers ... lectures will deal with history, types of stem cells, their derivation, characterization, differentiation and therapeutic applications/ ... legal and ethical issues surrounding stem cell research in India. Lab sessions will deal with ...
--> DOR BioPharma Receives $1.5 Million From Sigma-Tau Pharmaceuticals for Exclusive Right to Negotiate orBec(R) Strategic Alliance 1 Dec 2008 12:31 GMT
... of orBec® conducted at 16 leading bone marrow/stem cell transplantation centers in the US and France. Although ... lack of progress or positive results from research and development efforts, that it will be ...
DOR BioPharma Receives $1.5 Million From Sigma-Tau Pharmaceuticals for Exclusive Right to Negotiate 1 Dec 2008 12:30 GMT
... of orBec® conducted at 16 leading bone marrow/stem cell transplantation centers in the US and France. Although ... lack of progress or positive results from research and development efforts, that it will be ...
DOR BioPharma Receives $1.5 Million From Sigma-Tau Pharmaceuticals for Exclusive Right to Negotiate orBec(R) Strategic Alliance 1 Dec 2008 12:20 GMT
... of orBec(R) conducted at 16 leading bone marrow/stem cell transplantation centers in the US and France. Although ... lack of progress or positive results from research and development efforts, that it will be ...
UCC regulations 'restrict rogue scientists' 1 Dec 2008 11:53 GMT
... there are no legal guidelines for stemcell research in Ireland and a “rogue scientist could ... Italy, Brazil for instance, work with embryonic stem cells under ethical guidelines. A paper which came ... came out this week online in Cell Stem Cell shows the use of embryonic stem cells ...
ImmuneRegen(R) Appoints Wound Healing and Tissue Regeneration Expert Spencer A. Brown, Ph.D. to Advi 1 Dec 2008 11:52 GMT
... than 20 years experience as a clinical researcher and biotech company entrepreneur and advisor, is ... that includes preclinical and clinical studies in stem cells, dermatology, reconstructive surgery and wound healing mechanisms, ... ImmuneRegen's drug candidate, Homspera®, is an adult stem cell active compound that has been shown to ...
ImmuneRegen(R) Appoints Wound Healing and Tissue Regeneration Expert Spencer A. Brown, Ph.D. to Advisory Board 1 Dec 2008 11:50 GMT
... than 20 years experience as a clinical researcher and biotech company entrepreneur and advisor, is ... that includes preclinical and clinical studies in stem cells, dermatology, reconstructive surgery and wound healing mechanisms, ... ImmuneRegen's drug candidate, Homspera�, is an adult stem cell active compound that has been shown to ...

1 - 15 / 299 NEXT >>>

NOT SATISFIED WITH THIS STEM CELL RESEARCH NEWS SECTION? MAKE YOUR OWN WITH THE INBOX ROBOT OR TRY OUR OTHER MEDIA MONITORING SERVICES.

These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>>